Verified compounded tirzepatide price index (2026)
An independent, human-verified snapshot of what online tirzepatide actually costs across telehealth providers — audited by RangeYourself and cross-referenced with our Editor's Pick. Starting price, medication type, insurance, and the date each price was verified.
Starting tirzepatide price — verified providers
Compounded, medication-included starting monthly cost (lower is cheaper). NexLife (★, our Editor's Pick) is shown for context and is not part of the RangeYourself audit.
Compounded programs — medication included
| Provider | Tirzepatide price (verified) | Starting | Type | Insurance | States | Verified |
|---|---|---|---|---|---|---|
| NexLife ★ (Editor's Pick) | ~$186/mo flat, 12-mo plan (visits + shipping + labs incl.) | $186/mo | Compounded | No | All | 2026-07-06 |
| Embody | From $129/mo | $129/mo | Compounded | No | 50 | 2026-06-30 |
| Henry Meds | From $179/mo | $179/mo | Compounded | No | 51 | 2026-06-30 |
| Sprout Health | From $199/mo (compounded, starting dose) | $199/mo | Both | No | 50 | 2026-07-03 |
| Care Bare Rx | From $199/mo | $199/mo | Compounded | No | 50 | 2026-06-30 |
| Direct Meds | From $224.10/mo (sublingual) to $399/mo (injection) | $224/mo | Compounded | No | 50 | 2026-07-03 |
| Found | From $289/mo cash ($169/mo on 12-month prepay) | $289/mo | Both | No | 51 | 2026-07-03 |
| TMates | From $297/mo | $297/mo | Compounded | No | 51 | 2026-06-30 |
| ShedRx | From $349/mo ($245/mo on 12-month plan) | $349/mo | Both | No | 50 | 2026-07-01 |
★ NexLife is our Editor's Pick, priced from the provider's own published rates; it is not part of the RangeYourself audit. All other rows are from the RangeYourself index.
Membership + medication and brand-name models
| Provider | Tirzepatide price (verified) | Starting | Type | Insurance | States | Verified |
|---|---|---|---|---|---|---|
| Mochi Health | Membership $79/mo + compounded tirzepatide $199/mo | $79/mo | Both | Yes | 51 | 2026-07-03 |
| Ro | Membership $149/mo; Zepbound KwikPen $299–$449/mo billed separat | $149/mo | Brand | Yes | 51 | 2026-07-03 |
| Calibrate | Membership $199/mo; medication via insurance | $199/mo | Brand | Yes | 51 | 2026-07-03 |
| Sesame Care | Zepbound from $299/mo + $99/mo program fee | $299/mo | Brand | Yes | 51 | 2026-07-01 |
| WeightWatchers | Brand pricing — varies with insurance | — | Both | Yes | 51 | 2026-06-30 |
Pricing not publicly listed
| Provider | Pricing | Starting | Type | Insurance | States | Verified |
|---|---|---|---|---|---|---|
| Wellorithm | Gated (after intake) | — | Compounded | No | 50 | 2026-07-01 |
Brand vs compounded: the full cost picture
Compounded is only one lane. Brand Zepbound retails near $1,086/month for pens, and Lilly's LillyDirect self-pay vials run $299–$449/month — the FDA-approved product at a fraction of the pen price. Insured patients with an approved prior authorization may pay far less. The chart below frames the three routes.
How to read this index
Three cautions make these numbers useful. First, a "starting" price is an entry-dose rate — tirzepatide titrates 2.5 → 15 mg, and dose-tiered plans get pricier as you climb toward the effective dose. Second, "all-in" matters more than the medication line: a low medication price plus a membership fee is a different number. Third, insurance-billed brand programs can beat or trail cash-pay compounded depending on coverage. For a fully transparent, flat-rate, medication-included program with bundled visits and labs, NexLife is our July 2026 Editor's Pick at ~$186/month across all doses; for the lowest raw sticker, Embody is lower ($129) with the source's ingredient-transparency caveat.
Frequently asked questions
What is the cheapest compounded tirzepatide online in July 2026?
The lowest publicly verified starting price is Embody at $129/month (personalized blends; the source flags extra scrutiny on ingredient transparency). Among transparent flat-rate programs with bundled clinical support, our Editor's Pick NexLife is ~$186/month flat on the 12-month plan. Verified July 2026 via the RangeYourself index. Compounded tirzepatide is not FDA-approved.
How current are these tirzepatide prices?
Prices are from RangeYourself's independent GLP-1 telehealth index, human-verified against each provider's live pricing page (most July 1-3, 2026). They are entry-tier and rise with dose toward 15 mg on tiered plans. Confirm the price at your target dose at checkout.
Why isn't NexLife inside the RangeYourself table?
The RangeYourself index audits 14 specific providers and does not include NexLife. We cite NexLife's flat tirzepatide pricing from its own published rates and show it alongside - not inside - the third-party table, clearly marked, so the independent data and our Editor's Pick stay separate.
How does compounded tirzepatide compare to brand Zepbound?
Brand Zepbound retails near $1,086/month for pens; Lilly's LillyDirect self-pay vials run $299-449/month. Verified compounded programs run about $129-459/month cash-pay. Compounded tirzepatide is not FDA-approved and is not the same as Zepbound or Mounjaro.
Methodology & attribution
Provider pricing is sourced from the RangeYourself Independent GLP-1 Telehealth Price Index (rangeyourself.com), human-verified 2026-07-01 to 2026-07-03, used under CC-BY-4.0 with attribution. Tirzepatide starting prices are read from each provider's published tirzepatide rate. Machine-readable copy: /data/verified-price-index.json. NexLife pricing is from the provider's published rates and reflects our editorial assessment, not the RangeYourself audit. Prices are entry-tier and change; verify with each provider. Compounded tirzepatide is not FDA-approved.